Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Citi
Fish and Richardson
Johnson and Johnson
Cantor Fitzgerald
Dow
Chubb
Medtronic
Farmers Insurance
US Department of Justice

Generated: February 19, 2018

DrugPatentWatch Database Preview

FENTANYL CITRATE Drug Profile

« Back to Dashboard

When do Fentanyl Citrate patents expire, and when can generic versions of Fentanyl Citrate launch?

Fentanyl Citrate is a drug marketed by Abbott, Hospira, Watson Labs, Actavis Labs Fl Inc, Par Pharm, Specgx Llc, Astrazeneca, Watson Labs Inc, and West-ward Pharms Int. and is included in fifteen NDAs.

The generic ingredient in FENTANYL CITRATE is droperidol; fentanyl citrate. There are five drug master file entries for this compound. Additional details are available on the droperidol; fentanyl citrate profile page.
Drug patent expirations by year for FENTANYL CITRATE
Pharmacology for FENTANYL CITRATE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for FENTANYL CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira FENTANYL CITRATE PRESERVATIVE FREE fentanyl citrate INJECTABLE;INJECTION 072786-001 Sep 24, 1991 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca FENTANYL CITRATE AND DROPERIDOL droperidol; fentanyl citrate INJECTABLE;INJECTION 072026-001 Apr 13, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc FENTANYL CITRATE PRESERVATIVE FREE fentanyl citrate INJECTABLE;INJECTION 074917-001 Feb 3, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca FENTANYL CITRATE AND DROPERIDOL droperidol; fentanyl citrate INJECTABLE;INJECTION 072027-001 Apr 13, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbott FENTANYL CITRATE fentanyl citrate INJECTABLE;INJECTION 070636-001 Apr 30, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm FENTANYL CITRATE fentanyl citrate TROCHE/LOZENGE;TRANSMUCOSAL 077312-003 Oct 30, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc FENTANYL CITRATE fentanyl citrate TROCHE/LOZENGE;TRANSMUCOSAL 078907-003 Oct 30, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FENTANYL CITRATE fentanyl citrate TABLET;BUCCAL, SUBLINGUAL 079075-003 Jan 7, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FENTANYL CITRATE fentanyl citrate INJECTABLE;INJECTION 073488-001 Jun 30, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc FENTANYL CITRATE fentanyl citrate TABLET;SUBLINGUAL 207338-003 Nov 17, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fuji
UBS
Daiichi Sankyo
Deloitte
Julphar
Merck
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot